Similarly, even though the therapeutic effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on type 2 diabetes mellitus are understood, their effectiveness across sub-groups of age, ethnicities and renal function remains undefined. This evidence concerns the gene DPP4 and diabetes mellitus.